Literature DB >> 24029468

The use of pneumatic tourniquets is safe in Asians undergoing total knee arthroplasty without anticoagulation.

Hamid Rahmatullah Bin Abd Razak1, Hwee Chye Andrew Tan2.   

Abstract

BACKGROUND: There has always been controversy surrounding the use of pneumatic tourniquets in total knee arthroplasty (TKA) as they have been implicated in venous thromboembolic events (VTE). We aimed to evaluate the incidence of clinically significant VTE in Asians who underwent conventional TKA under tourniquet throughout the duration of surgery, without post-operative chemical VTE prophylaxis, but using post-operative pneumatic compression devices.
METHODS: Five hundred and thirty-one patients of a single surgeon who underwent elective total knee arthroplasty were retrospectively reviewed. All patients had a tourniquet applied to the operated limb. None of the patients received chemoprophylaxis against VTE. Post-operatively, only symptomatic patients were referred for ultrasonography. The patients were then stratified according to the tourniquet time: <60, 61 to 90, 91 to 120, and >120 min. The overall incidence as well as the incidence of venous thromboembolic events for each group was then calculated.
RESULTS: Of the 531 patients reviewed, 3 patients suffered from deep venous thrombosis (DVT) while 1 patient developed a fatal pulmonary embolism (PE). Hence, the overall incidence of clinically significant VTE was 0.75%. The 3 patients with DVT had tourniquet time of 61 to 90 min while the patient with PE had a tourniquet time of more than 120 min.
CONCLUSION: With a low overall incidence of VTE, the use of tourniquet in Asians during conventional total knee arthroplasty appears safe when post-operative pneumatic compression devices are used instead of chemical VTE prophylaxis. However, the risk of VTE seems to increase with a tourniquet time of more than 60 min. LEVEL OF EVIDENCE: Therapeutic studies, level III.
© 2013.

Entities:  

Keywords:  Total knee arthroplasty; Tourniquet; Venous thromboembolism

Mesh:

Year:  2013        PMID: 24029468     DOI: 10.1016/j.knee.2013.08.008

Source DB:  PubMed          Journal:  Knee        ISSN: 0968-0160            Impact factor:   2.199


  7 in total

1.  CORR Insights(®): Does Tourniquet Use in TKA Affect Recovery of Lower Extremity Strength and Function? A Randomized Trial.

Authors:  Keun Jung Ryu
Journal:  Clin Orthop Relat Res       Date:  2015-07-03       Impact factor: 4.176

2.  Does Tourniquet Use in TKA Affect Recovery of Lower Extremity Strength and Function? A Randomized Trial.

Authors:  Douglas A Dennis; Andrew J Kittelson; Charlie C Yang; Todd M Miner; Raymond H Kim; Jennifer E Stevens-Lapsley
Journal:  Clin Orthop Relat Res       Date:  2016-01       Impact factor: 4.176

3.  Deep vein thrombosis in arthroscopic surgery and chemoprophylaxis recommendation in an Asian population.

Authors:  Kuei Siong Andy Yeo; Wen Siang Kevin Lim; Yee Han Dave Lee
Journal:  Singapore Med J       Date:  2016-08       Impact factor: 1.858

4.  Incidence of deep vein thrombosis before and after total knee arthroplasty without pharmacologic prophylaxis: a 128-row multidetector CT indirect venography study.

Authors:  Moon Jong Chang; Min Kyu Song; Min Gyu Kyung; Jae Hoon Shin; Chong Bum Chang; Seung-Baik Kang
Journal:  BMC Musculoskelet Disord       Date:  2018-07-31       Impact factor: 2.362

5.  Elastic pneumatic tourniquet cuff can reduce postoperative thigh pain after total knee arthroplasty: a prospective randomized trial.

Authors:  Jae-Young Park; Sung Eun Kim; Myung Chul Lee; Hyuk-Soo Han
Journal:  BMC Musculoskelet Disord       Date:  2020-08-21       Impact factor: 2.362

6.  Efficacy of aminocaproic acid in the control of bleeding after total knee and hip arthroplasty: A systematic review and meta-analysis.

Authors:  Yihua Li; Jianwen Wang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

7.  Potential Risk Factors Contributing to Development of Venous Thromboembolism for Total Knee Replacements Patients Prophylaxed With Rivaroxaban: A Retrospective Case-Control Study.

Authors:  Owais Mian; Davide Matino; Robin Roberts; Ellen McDonald; Anthony K C Chan; Howard H W Chan
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.